Reuss, David 1976-
David E Reuss researcher
VIAF ID: 169342124 (Personal)
Permalink: http://viaf.org/viaf/169342124
Preferred Forms
- 100 0 _ ‡a David E Reuss ‡c researcher
- 100 1 _ ‡a Reuss, David ‡d 1976-
- 100 1 _ ‡a Reuss, David ‡d 1976-
4xx's: Alternate Name Forms (5)
5xx's: Related Names (3)
- 551 _ _ ‡a Berlin ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Universität Heidelberg ‡b Pathologisches Institut ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Accurate calling of KIAA1549-BRAF fusions from DNA of human brain tumours using methylation array-based copy number and gene panel sequencing data | |
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities | |
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry | |
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. | |
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. | |
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience | |
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas | |
Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p | |
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma | |
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM | |
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma | |
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma. | |
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. | |
GENE-12. ANAPLASTIC NEUROEPITHELIAL TUMOR WITH CONDENSED NUCLEI (ANTCON): A NOVEL BRAIN TUMOR ENTITY WITH RECURRENT NTRK FUSION | |
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype | |
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity | |
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens | |
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. | |
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course | |
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence. | |
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles. | |
Methylation-based classification of benign and malignant peripheral nerve sheath tumors | |
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation | |
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis | |
Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis | |
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. | |
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma | |
MYCN amplification drives an aggressive form of spinal ependymoma | |
Neurofibromin hemmt das Tumorzellwachstum durch RasGAP-unabhängige Suppression des Klasse II Transaktivators | |
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets | |
Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. | |
Nuclear relocation of STAT6 reliably predicts NAB2-STAT6 fusion for the diagnosis of solitary fibrous tumour | |
Oligosarcomas, IDH-mutant are distinct and aggressive | |
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA | |
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive Tumors. | |
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation | |
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. | |
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. | |
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis | |
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B | |
Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry. | |
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors | |
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 | |
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions | |
Sarcoma classification by DNA methylation profiling | |
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations | |
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR | |
TERT Promoter Mutations and Risk of Recurrence in Meningioma | |
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade | |
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities | |
Whole exome sequencing reveals that the majority of schwannomatosis cases remain unexplained after excluding SMARCB1 and LZTR1 germline variants | |
YAP1-fusions in pediatric NF2-wildtype meningioma |